A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)

Conditions

• Pulmonary Arterial Hypertension

Interventions

• DRUG: Placebo
• DRUG: Sotatercept
• OTHER: SOC

Sponsor

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA